#181 – Robert Gatenby, M.D.: Viewing cancer through an evolutionary lens and why this offers a radically different approach to treatment
“For a century we’ve been looking for magic bullets, but maybe all we need is a series of pretty good bullets.” —Bob Gatenby
#180 – AMA #28: All things testosterone and testosterone replacement therapy
“There were countless other studies to look at, but they all basically point in the same direction, which is testosterone replacement therapy improves lean mass, reduces fat mass, improves strength.” —Peter Attia
#173 – AMA #26: Continuous glucose monitors, zone 2 training, and a framework for interventions
“Zone two is a metabolic state. It’s not determined by speed. It’s determined by which energy system you’re requiring and what the equilibrium is.” —Peter Attia
#170 – AMA #25: Navigating the complexities and nuances of cancer screening
“We screen often, we screen early, and we screen aggressively.” —Peter Attia
A new frontier for early cancer detection?
Discussing the GRAIL blood test
Rapamycin: one of my favorite stories; Ryan Lochte’s flip side on missing Olympic redemption
A few things worth checking out: 07-18-2021
Brain implants and identity; recovering a fallen Marine’s Purple Heart
A few things worth checking out: 06-27-2021
#166 – Patricia Corby, D.D.S.: Importance of oral health, best hygiene practices, and the relationship between poor oral health and systemic disease
“You can maintain optimal oral health just by brushing teeth, by flossing really well, and having good nutrition.” —Pat Corby
A hope for treating Alzheimer’s disease?
The FDA approves the first new medication for AD, aducanumab, in two decades
MDMA for PTSD?
MDMA-assisted therapy gets one step closer to its projected 2023 FDA approval